| Trademark Snap Shot Amendment & Mail Processing Stylesheet (Table presents the data on Amendment & Mail Processing Complete) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 88207119 | FILING DATE | 11/27/2018 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | EL-BAYEH, ALEXANDRA E |
L.O. ASSIGNED | N60-NOT FOUND |
PUB INFORMATION |
|||
| RUN DATE | 12/06/2019 | ||
| PUB DATE | 04/09/2019 | ||
| STATUS | 814-SU - RESPONSE AFTER NON-FINAL ACTION - ENTERED | ||
| STATUS DATE | 12/05/2019 | ||
| LITERAL MARK ELEMENT | INREBIC | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | NO |
| LITERAL MARK ELEMENT | INREBIC |
| MARK DRAWING CODE | 3-AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/LETTER(S)/NUMBER(S) |
| COLOR DRAWING FLAG | YES |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 20-OWNER AT PUBLICATION |
| NAME | IMPACT BIOMEDICINES, INC. |
| ADDRESS | 86 MORRIS AVENUE SUMMIT, NJ 07901 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Delaware |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Pharmaceutical preparations for use in the treatment of myeloproliferative diseases, myelofibrosis, autoinflammatory disease, autoimmune disease, blood disease, cancer in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | 08/16/2019 | FIRST USE IN COMMERCE DATE | 08/16/2019 | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
| COLORS CLAIMED STATEMENT | The color(s) blue and grey is/are claimed as a feature of the mark. |
| DESCRIPTION OF MARK | The mark consists of a prism in the shape of a V made up varying colors of blue and grey over the letter "E" of "INREBIC" in blue block lettering. |
| OWNER OF US REG NOS | 4931750 |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 12/05/2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 024 |
| 12/05/2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 023 |
| 12/02/2019 | ALIE | A | ASSIGNED TO LIE | 022 |
| 11/22/2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 021 |
| 11/15/2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 020 |
| 11/15/2019 | GNRT | F | NON-FINAL ACTION E-MAILED | 019 |
| 11/15/2019 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | 018 |
| 10/25/2019 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | 017 |
| 10/07/2019 | IUAF | S | USE AMENDMENT FILED | 016 |
| 10/25/2019 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | 015 |
| 10/07/2019 | EISU | I | TEAS STATEMENT OF USE RECEIVED | 014 |
| 06/04/2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 013 |
| 04/09/2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 012 |
| 04/09/2019 | PUBO | A | PUBLISHED FOR OPPOSITION | 011 |
| 03/20/2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 010 |
| 02/26/2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 009 |
| 02/25/2019 | DOCK | D | ASSIGNED TO EXAMINER | 008 |
| 01/10/2019 | AMPX | O | APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED | 007 |
| 01/09/2019 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 006 |
| 01/09/2019 | ALIE | A | ASSIGNED TO LIE | 005 |
| 01/04/2019 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | 004 |
| 12/15/2018 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | 003 |
| 12/14/2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 11/30/2018 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Camille M. Miller |
| CORRESPONDENCE ADDRESS | CAMILLE M. MILLER COZEN O'CONNOR Suite 2800 1650 MARKET STREET PHILADELPHIA, PA 19103 |
| DOMESTIC REPRESENTATIVE | NONE |
PRIOR OWNER INFORMATION |
|
| PARTY TYPE | 11-SUBSEQUENT OWNER BEFORE PUBLICATION |
| NAME | IMPACT BIOMEDICINES, INC. |
| ADDRESS | 86 MORRIS AVENUE SUMMIT, NJ 07901 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Delaware |
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Celgene Corporation |
| ADDRESS | 86 Morris Avenue Summit, NJ 07901 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Delaware |